中国武汉2019新型冠状病毒感染患者的临床特征
研究前瞻性纳入截至2020年1月2日武汉定点医院41例实验室确诊2019-nCoV感染住院患者,分析流行病学、临床、实验室、影像及治疗结局。常见起病症状为发热40例(98%)、咳嗽31例(76%)、肌痛或乏力18例(44%);全部41例胸部CT均有肺炎异常表现。13例(32%)入住ICU,6例(15%)死亡;ICU患者血浆IL2、IL7、IL10、GSCF、IP10、MCP1、MIP1A和TNFα水平高于非ICU患者。
要点
- 41例确诊患者中发热40例(98%)、咳嗽31例(76%),全部有胸部CT肺炎表现。
- 13例(32%)入住ICU,6例(15%)死亡,重症与高死亡率需警惕。
- ICU患者多种细胞因子水平高于非ICU患者,提示炎症反应与病情严重度相关。
核心结论
- 2019-nCoV感染导致类似SARS冠状病毒的严重呼吸道疾病聚集性疫情,与ICU入住和高死亡率相关。
研究设计与样本
- 前瞻性收集武汉定点医院实验室确诊2019-nCoV感染住院患者数据,采用WHO与国际严重急性呼吸道和新兴感染联盟共享的标准化表单从电子病历获取数据。
- 截至2020年1月2日共纳入41例实验室确诊2019-nCoV感染住院患者,并比较ICU与非ICU患者的结局。
主要发现
- 27例(66%)有华南海鲜市场暴露史,发现一个家庭聚集性病例。
- 起病常见症状为发热40例(98%)、咳嗽31例(76%)、肌痛或乏力18例(44%)。
- 并发症包括急性呼吸窘迫综合征12例(29%)、RNA血症6例(15%)、急性心脏损伤5例(12%)、继发感染4例(10%)。
关键数值与推荐
- 13例(32%)入住ICU,6例(15%)死亡。
- ICU患者血浆IL2、IL7、IL10、GSCF、IP10、MCP1、MIP1A和TNFα水平高于非ICU患者。
临床怎么用
- 对发热、咳嗽、肌痛或乏力患者应结合流行病学史及胸部CT肺炎表现警惕2019-nCoV感染。
- 淋巴细胞减少及细胞因子水平升高可能提示病情较重,需密切监测并评估ICU收治需求。
局限性
- 对病毒起源、流行病学、人际传播持续时间和疾病临床谱的认知存在重大空白,需未来研究填补。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients. METHODS: All patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan. We prospectively collected and analysed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing. Data were obtained with standardised data collection forms shared by WHO and the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records. Researchers also directly communicated with patients or their families to ascertain epidemiological and symptom data. Outcomes were also compared between patients who had been admitted to the intensive care unit (ICU) and those who had not. FINDINGS: By Jan 2, 2020, 41 admitted hospital patients had been identified as having laboratory-confirmed 2019-nCoV infection. Most of the infected patients were men (30 [73%] of 41); less than half had underlying diseases (13 [32%]), including diabetes (eight [20%]), hypertension (six [15%]), and cardiovascular disease (six [15%]). Median age was 49·0 years (IQR 41·0-58·0). 27 (66%) of 41 patients had been exposed to Huanan seafood market. One family cluster was found. Common symptoms at onset of illness were fever (40 [98%] of 41 patients), cough (31 [76%]), and myalgia or fatigue (18 [44%]); less common symptoms were sputum production (11 [28%] of 39), headache (three [8%] of 38), haemoptysis (two [5%] of 39), and diarrhoea (one [3%] of 38). Dyspnoea developed in 22 (55%) of 40 patients (median time from illness onset to dyspnoea 8·0 days [IQR 5·0-13·0]). 26 (63%) of 41 patients had lymphopenia. All 41 patients had pneumonia with abnormal findings on chest CT. Complications included acute respiratory distress syndrome (12 [29%]), RNAaemia (six [15%]), acute cardiac injury (five [12%]) and secondary infection (four [10%]). 13 (32%) patients were admitted to an ICU and six (15%) died. Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα. INTERPRETATION: The 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was associated with ICU admission and high mortality. Major gaps in our knowledge of the origin, epidemiology, duration of human transmission, and clinical spectrum of disease need fulfilment by future studies. FUNDING: Ministry of Science and Technology, Chinese Academy of Medical Sciences, National Natural Science Foundation of China, and Beijing Municipal Science and Technology Commission.
引用
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020. PMID: 31986264. doi:10.1016/S0140-6736(20)30183-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。